Market Insights report
Lipid-lowering agents are used to treat metabolic disorders (e.g., hyperlipidemia or dyslipidemia) which are characterized by high levels of lipids, such as fats, cholesterol, or triglycerides, or lipoproteins in the blood. Different drug classes are included: statins, PCSK9 inhibitors, bile acid sequestrants, cholesterol absorption inhibitors, fibric acid derivatives, as well as combinations thereof.
What's included?
The Lipid-Lowering Agents market covers drugs to treat hyperlipidemia or dyslipidemia. As therapies with lipid-lowering agents are usually of a long-term nature, the growth of this market is rather driven by the prices of these products than by the number of patients. Nevertheless, limited access to healthcare facilities owing to the COVID-19 pandemic has had some negative impact, which is reflected in lower growth rates in 2020. While generics have a considerable share, expiring patents as well as new products strongly influence the dynamics of the market.
Overview
Market numbers
We provide information on industries, companies, consumers, trends, countries, and politics, covering the latest and most important issues in a condensed format.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)